|Mr. Laiwang Zhang||9.55k||N/A||55|
|Ms. Dongdong Lin||9.49k||N/A||43|
|Ms. Fanjun Wu||N/A||N/A||43|
|Mr. Jeffrey G. Reynolds||N/A||N/A||55|
|Mr. Chengxiang Yan||N/A||N/A||49|
Sunwin Stevia International, Inc. produces and sells stevioside, a natural sweetener; and herbs used in traditional Chinese medicines and veterinary products primarily in the Peoples Republic of China. It operates through two segments, Stevioside and Chinese Medicines. The Stevioside segment produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. Its products include Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie, dietary supplement. This segment sells its products to food and drug manufacturers, and ingredient distributor foreign trade companies. The Chinese Medicines segment manufactures and sells traditional Chinese medicine formula extracts, which are used in products made for use by humans and animals. Its extracts consists of single traditional Chinese medicine extracts; compound traditional Chinese medicine extracts; and purified extracts, including active parts and monomer compounds, such as soy isoflavone. This segment offers traditional Chinese medicine formula extracts to traditional Chinese medicine manufacturers and animal pharmaceutical manufacturers. Sunwin Stevia International, Inc. is based in Qufu, China.
Sunwin Stevia International, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.